跳至主要内容
临床试验/NCT00525304
NCT00525304已完成不适用

Optimizing Chronic Illness Self-Management for Individuals With Schizophrenia

University of Maryland, Baltimore2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2007年9月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
2
主要终点
Medical illness self-management skills

研究概览

简要总结

This study will develop and evaluate the effectiveness of a self-management program for adults living with both schizophrenia and a co-occurring medical condition.

详细描述

Schizophrenia is a life-long brain disorder affecting approximately 1 percent of Americans each year. Schizophrenia can be extremely disabling, causing people to hear voices, experience paranoia or hallucinations, and believe that others are controlling their thoughts. People with schizophrenia also experience increased rates of concurrent medical conditions, such as diabetes, respiratory illness, and heart disease. This can make holding a job or even caring for oneself very difficult. The purpose of this study is to develop and evaluate a self-management program for adults living with both schizophrenia and a concurrent medical condition.

Participants in this open-label study will attend 10 to 16 group sessions led by two group leaders. Group sessions will meet each week for an hour during which participants will learn new skills to help them take responsibility for the daily management of chronic medical conditions. In addition to learning how to communicate more effectively with medical providers, participants will learn about healthy eating, the importance of physical activity, addictive behaviors that can worsen health conditions, and proper use of medications. Homework will be assigned weekly for participants to review skills learned in each session. After each session, participants will complete a survey to evaluate the session's effectiveness. At the end of the study, participants will attend one additional group meeting and an individual interview to discuss the overall effectiveness of the intervention and their experiences in the group sessions. The results of this study will be used to evaluate and improve the self-management program for future use.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Meets DSM-IV criteria for schizophrenia or schizoaffective disorder
  • Current documented chart diagnosis of at least one chronic medical condition
  • Received clinic services for a minimum of 3 months prior to study entry
  • English-speaking
  • Willing to use an effective form of birth control throughout the study if sexually active

排除标准

  • History of a serious neurological disorder or head trauma with loss of consciousness
  • Diagnosed with mental retardation or dementia
  • Diagnosed with end stage organ disease
  • Currently receiving chemotherapy and/or radiation treatment for cancer
  • Received psychiatric hospitalization less than 3 months prior to study entry date
  • Blind and/or deaf
  • Infected with HIV with a CD4 count under 350
  • Diagnosis of AIDS
  • Diagnosis of anorexia
  • Problematic substance use, as defined by a mental health provider
  • Psychiatric instability, as defined by a mental health provider

研究组 & 干预措施

1

Experimental

Participants will receive a self-management program for chronic illness

干预措施: Self-management program for chronic illness (Behavioral)

Usaual Care

No Intervention

Usual Care; no additional intervention

结局指标

主要结局

Medical illness self-management skills

时间窗: Measured at pre- and post-intervention

Physical and mental health status

时间窗: Measured at pre- and post-intervention

Medical service use patterns

时间窗: Measured at pre- and post-intervention

Social and communication skills during interactions with health care providers

时间窗: Measured at pre- and post-intervention

Health-related self-efficacy and recovery orientation

时间窗: Measured at pre- and post-intervention

次要结局

  • Psychiatric symptoms(Measured at pre- and post-intervention)
  • Amount and seriousness of related comorbidities(Measured at pre- and post-intervention)
  • Medication use(Measured throughout the study)
  • Neurocognition(Measured at baseline)
  • Substance abuse(Measured at pre- and post-intervention)
  • Quantitative and qualitative survey ratings(Measured throughout the study)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Richard Goldberg

PI

University of Maryland, Baltimore

研究点 (2)

Loading locations...

相似试验